Geert J.L.H. van Leenders

Author

Also Known As

Agnes Jager, Anna M. Leliveld, Arno van Leenders, Downes, Michelle, G J L H Van Leenders, G J L H van Leenders, G LEENDERS, G. J. L. H. van Leenders, G. J.L.H. van Leenders, G.J.L.H. Leenders

350

Publications

14.5K

Citations

H-Index

Concepts

All Affiliations

Erasmus MC Erasmus University Rotterdam Erasmus MC Cancer Institute Radboud University Nijmegen University Health Network

About

Geert J.L.H. van Leenders is an author at Erasmus MC specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	55	4.9K
2	Engineering	7	7	436
3	Health Sciences	6	6	229
4	Public Health	4	4	376
5	Natural Sciences	1	1	93

Geert J.L.H. van Leenders

132

Publications

9.2K

Citations

H-Index

Page 1

	Year	Citations
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma Geert J.L.H. van Leenders, Theodorus van der Kwast, David J. Grignon, The American Journal of Surgical Pathology	2020	624
Update of Dutch Multicenter Dose-Escalation Trial of Radiotherapy for Localized Prostate Cancer Abrahim Al‐Mamgani, Wim L.J. van Putten, Wilma D. Heemsbergen, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyUrologyRadiation TherapyMedicineLocalized Prostate Cancer	2008	416
Discrimination of Prostate Cancer from Normal Peripheral Zone and Central Gland Tissue by Using Dynamic Contrast-enhanced MR Imaging Marc Engelbrecht, Henkjan Huisman, Robert J.F. Laheij, Radiology	2003	381
Succinate Dehydrogenase (SDH)-deficient Renal Carcinoma Anthony J. Gill, Ondřej Hes, Thomas Papathomas, The American Journal of Surgical Pathology Succinate DehydrogenaseUrologyTumoral PathologyGenitourinary CancerKidney Research	2014	330
Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer Elena S. Martens‐Uzunova, Sanni E. Jalava, N. F. J. Dits, Oncogene UrologyFunctional GenomicsPrognostic SignaturesMedicinePathology	2011	275
A Critical Analysis of the Tumor Volume Threshold for Clinically Insignificant Prostate Cancer Using a Data Set of a Randomized Screening Trial Tineke Wolters, Monique J. Roobol, Pim J. van Leeuwen, The Journal of Urology	2010	274
Intermediate Cells in Human Prostate Epithelium Are Enriched in Proliferative Inflammatory Atrophy Geert J.L.H. van Leenders, Wesley R. Gage, Jessica Hicks, American Journal Of Pathology InflammationCytokineUrologyProliferative Inflammatory AtrophyChronic Inflammation	2003	212
Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder Cancer Bas W.G. van Rhijn, Tahlita C.M. Zuiverloon, André N. Vis, European Urology UrologyCancer RiskUrologic Cancer EpidemiologyGenitourinary CancerMedicine	2010	190
A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage Bas W.G. van Rhijn, Theodorus van der Kwast, Sultan S. Alkhateeb, European Urology Urogenital RadiologyUrological ResearchUrologyGenitourinary CancerMedicine	2011	189
A Prostate Cancer “ Nimbosus ”: Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies Melvin L.K. Chua, Winnie Lo, Melania Pintilie, European Urology UrologyMedicinePathologyCancer GenomicsCribriform Subpathologies	2017	180

Page 1